Kim-Hien T. Dao, D.O., Ph.D.

Head Shot of Kim-Hien Dao
click here
503 494-5058


Dr. Kim-Hien Dao received her post-doctoral internal medicine training at Scripps Mercy Hospital in San Diego, California, and hematology/oncology fellowship training at the University of California, San Diego. During her fellowship she was awarded a two-year Clinical Scholar Fellowship from the California Institute for Regenerative Medicine. Her faculty mentor was Dr. Catriona Jamieson. She works with other scientists on several clinical trials (research studies), and plans to start her own clinical trials of new treatments for patients with myelodysplastic syndromes that are very likely to become leukemia. She spends much of her day in the laboratory, studying how blood diseases become leukemia. Dr. Dao hopes her research will help develop treatments to stop the development of leukemia.

Selected Publications

"Significant clinical response to JAK1/2 inhibition in a patient with CSF3R-T618I-positive atypical chronic myeloid leukemia," Leukemia Research Reports (Vol: 3, Issue: 2, Page 67-69) - 2015

"A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition," Cell Stem Cell (Vol: 12, Issue: 3, Page 316-328) - 2013

"ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia," Proceedings of the National Academy of Sciences of the United States of America (Vol: 110, Issue: 3, Page 1041-1046) - 2013

"Next-generation medicine: Combining BCR-ABL and hedgehog-targeted therapies," Clinical Cancer Research (Vol: 19, Issue: 6, Page 1309-1311) - 2013

"The PI3K/Akt1 pathway enhances steady-state levels of FANCL," Molecular Biology of the Cell (Vol: 24, Issue: 16, Page 2582-2592) - 2013


OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


  Email Kim-Hien Dao

503 494-5058

Memberships & Associations

American Society of Hematology